Heidelberg (ots) - Roche and BioMed X announced today that they have entered into a collaboration agreement to establish a research group focusing on the development of a novel sensor technology platform based on new nanomaterials such as graphene. Outstanding early career scientists from leading academic ...
Parma And Modena, Italy (ots/PRNewswire) - The collaboration between a public excellent research center and a solid private pharmaceutical company allowed to achieve an extraordinary result, entirely "made in Italy": the first medicinal product containing stem cells approved in the Western world The European Commission has granted a conditional marketing authorization, ...
Darmstadt, Germany And Barcelona, Spain (ots/PRNewswire) - - Vall d'Hebron, Spain: first hospital to use liquid biopsy RAS biomarker testing technology - Leading research center will use technology to evolve understanding of who will benefit most from targeted treatment to improve patient outcomes - Liquid biopsy ...
Centre hospitalier Universitaire de Sherbrooke
Sherbrooke, Quebec (ots/PRNewswire) - - Download photos and videos at http://cr.chus.qc.ca/cyclotron-crchus #cyclotronCRCHUS Researchers at the Centre de research du Centre hospitalier universitaire de Sherbrooke (CRCHUS) unveiled today the results of a clinical study demonstrating equivalency between ...
Darmstadt, Germany (ots/PRNewswire) - In the news release, "Merck Strengthens Presence as Leading Oncology Company by Taking Full Promotional Responsibility for Erbitux in Japan" issued on 13 Feb 2015 06:33 GMT, by Merck over PR Newswire, we are advised by a representative of the company that in the third paragraph ...
Darmstadt, Germany (ots/PRNewswire) - - Not intended for US- and UK-based media - Merck and Bristol-Myers Squibb to end co-promotion of Erbitux in Japan, with full promotional responsibilities transferring to Merck Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts (ots/PRNewswire) - Shire plc announced today that the U.S. Food and Drug Administration (FDA) approved Vyvanse(R) (lisdexamfetamine dimesylate) Capsules (CII), the first and only medication for the treatment of moderate to severe binge eating disorder (B.E.D.) in adults, shown to ...
Shire Pharmaceuticals Group Plc
Lexington, Massachusetts And Zug, Switzerland (ots/PRNewswire) - Shire plc announces that it has for the first time placed in the Global 100 Sustainability Index. Shire was ranked 62nd in the index, which is being revealed during the World Economic Forum in Davos this week. The Global 100 Index is a global ranking by Canada-based media and investment advisory company, Corporate Knights, of the top sustainability ...
Conakry, Guinea (ots/PRNewswire) - UC RUSAL , a leading global aluminium producer, announces that construction of the "Centre for epidemic and microbiological research and treatment" in the Kindia administrative region of the Republic of Guinea has completed. The Centre will support Guinea's national health system and help fight the spread of the Ebola virus. The opening ceremony which took place on 17 January was ...
Chertsey, England (ots/PRNewswire) - $150,000 Grant will be awarded on Saturday 24th January The Astellas European Foundation has announced the shortlist for the Transplantation Grant. The Grant programme supports basic medical and related scientific programmes which contribute to advancements in transplantation. The five finalists are from Denmark, Germany, The ...
Lausanne, Switzerland (ots/PRNewswire) - GenePOC is a Canadian company which has developed a rapid, innovative, low cost MDx platform for the detection of infectious diseases Debiopharm Diagnostics [https://www.debiopharm.com/about-us/debiopharm-diagnostics-s-a.html ], part of Debiopharm Group [https://www.debiopharm.com/about-us/debiopharm-group.html ](TM), is proud ...
Lausanne, Switzerland (ots/PRNewswire) - - Novartis returns Alisporivir (DEB025) to Debiopharm Group(TM) including all rights for HCV and other indications - Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company, today announced that it has updated its arrangement with Novartis to regain full rights to Alisporivir (DEB025) currently completing two Phase 2 studies of interferon-free treatment in ...
Dublin And Bedminster, New Jersey (ots/PRNewswire) - Transaction valued at $5.2 billion Enhances growth profile Shire plc and NPS Pharmaceuticals, Inc. today announced that the companies have entered into a merger agreement pursuant to which Shire will acquire all the outstanding shares of NPS Pharma for $46.00 per share in cash, for a total consideration of ...
London (ots/PRNewswire) - Hikma Pharmaceuticals PLC ("Hikma") , the fast growing multinational pharmaceutical group, today notes that Takeda Pharmaceuticals U.S.A. Inc. ("Takeda") has been unsuccessful in appealing the decision by the United States District Court for the District of Delaware to deny Takeda's motion for a preliminary injunction in relation to the distribution of Hikma's colchicine 0.6mg capsules for the ...
Lausanne, Switzerland (ots/PRNewswire) - - Debio 1450, oral/IV FabI inhibitor active against all Staphylococcus species has received Fast Track designation for ABSSSI (acute bacterial skin and skin structure infections) - Debiopharm Group(TM) (Debiopharm), a Swiss-based global biopharmaceutical company, today announced that the US Food and Drug Administration (FDA) ...
Ballerup, Denmark (ots/PRNewswire) - - Not Intended for US Media LEO Pharma announced it has submitted a New Drug Application to the US Food and Drug Administration (FDA) for calcipotriene/betamethasone dipropionate aerosol foam 0,005%/0,064% for the treatment of psoriasis vulgaris. (Logo: http://photos.prnewswire.com/prnh/20130221/595427 ) The novel aerosol foam ...
Nuremberg, Germany (ots/PRNewswire) - - Mexico and China have the highest number of consumers who claim to exercise on a regular basis to maintain their physical health - Over eight in ten Indonesians regularly get enough sleep to maintain their physical health - in contrast to just over half of Russians GfK asked consumers around the world what activities they ...
Cork, Ireland (ots/PRNewswire) - -- Two Companies to also Collaborate on the Further Development of Complera(R), Marketed as Eviplera(R) in the European Union -- Janssen R&D Ireland (Janssen) announced today an amendment to its existing agreement with Gilead Sciences, Inc. (Gilead), initially established in 2011, ...
Luxembourg (ots/PRNewswire) - Boulle Medtech Ltd, a Jean Boulle Group company focusing on medical technology and a founding investor of Tendyne Holdings, Inc. ("Tendyne"), is pleased to announce that the Tendyne Transcatheter Mitral Valve Implant (TMVI) was successfully placed in the first patient enrolled in a ...
Woodbridge, Ontario (ots/PRNewswire) - Pivotal Therapeutics Inc. (OTCQX:PVTTF; CSE:PVO), ("Pivotal" or the "Company"), a specialty pharmaceutical company with a focus on Omega-3 therapies for cardiovascular disease (CVD) and overall health, announced that on December 16, 2014 the French FDA in Paris (ANSM: Agence Nationale de la Sécurité du Médicament - French ...
Luxembourg (ots/PRNewswire) - Boulle Medtech Ltd., a Jean Boulle Group private company focusing on medical technology, and founding investor of Tendyne Holdings, Inc. ("Tendyne"), is pleased to announce that Tendyne's Transcatheter Mitral Valve device has been successfully implanted in three patients. The procedures ...
Darmstadt, Germany (ots/PRNewswire) - - Merck Serono's Grant for Growth Innovations (GGI) supports innovative projects to advance understanding in the field of growth - Closing date for entries is January 6, 2015 - Awardees will be announced at the European Society for Paediatric Endocrinology meeting in Barcelona, October 2015 Merck Serono, the biopharmaceutical ...
Buffalo Grove, Illinois (ots/PRNewswire) - Leica Biosystems, a global leader in anatomic pathology laboratory solutions and instruments, announced today that it has successfully completed its previously announced acquisition of Devicor Medical Products, Inc. Devicor is a global market leader in breast biopsy instruments and consumables, with annual revenues of approximately $170 million. It is committed to advancing ...
Brussels (ots/PRNewswire) - Event coincides with the publication in The Lancet Infectious Diseases of EUCLID - the largest epidemiology study on Clostridium difficile infection[1] CDI Europe, the European Hospital and Healthcare Federation (HOPE) and MEP Karin Kadenbach today hosted an event at the European ...
Stockholm (ots/PRNewswire) - A customized version of SyntheticMR AB's SyMRI(R) IMAGE software is now introduced by GE Healthcare, a strategic partner to SyntheticMR, under the name MAGiC. MAGiC is introduced at RSNA together with the new magnetic resonance (MR) system SIGNA Pioneer from GE Healthcare. MAGiC (Magnetic Resonance Image Compilation) is a customized version of SyntheticMR's SyMRI IMAGE software, a breakthrough ...
Munich (ots/PRNewswire) - - Survey findings show that 97% of European cardiologists believe that non-valvular atrial fibrillation (NVAF) patients experience a delay in diagnosis,[1] which is associated with a higher risk of stroke[2] - European Cardiologists reveal the importance of reviewing patient ...
Mumbai, India (ots/PRNewswire) - Cipla Europe NV ("Cipla"), a global pharmaceutical company is delighted to announce that it has signed a distribution agreement with Serum Institute of India Ltd. (SII) - a global leader in the production of vaccines. Under the agreement, SII will develop and manufacture paediatric ...
Lyon, France (ots/PRNewswire) - Clostridium difficile infection,a potentially fatal disease,[2]is at leasttwice as common as MRSA infections in hospitals[3],[4]and is estimated to cost the EU EUR3 billion per annum[5] A first of its kind expert consensus report on Clostridium difficile infection (CDI), contributed ...
Bagsværd, Denmark (ots/PRNewswire) - Today, on World Diabetes Day, the Chinese cities of Tianjin and Shanghai join the Cities Changing Diabetes initiative and the global fight against the urban diabetes epidemic. These two major metropolitan centres are the first Chinese cites to become part of the global partnership programme, which was initiated in Mexico City in ...
Bristol-Myers Squibb GmbH & Co. KGaA
Paris (ots/PRNewswire) - The Partnering for Cure faculty of experts today announced the four recipients of awards for research proposals that will help to provide insights into the pathophysiology of viral diseases and the potential development of cure strategies in HIV, hepatitis B (HBV) and hepatitis C (HCV). As ...